
This study systematically reviewed the short‐term efficacies of any cCSC treatment tested in randomized controlled trials (RCT) and employed network meta‐analyses to compare to non‐treatment controls. In conclusion, three treatment options significantly improve over no treatment: half‐dose/‐fluence PDT, conventional laser and much lesser degree SRT. Considering that conventional laser can only be applied for extrafoveal leaks and the long‐term data available for PDT‐based treatments finding persisting treatment results, half‐dose or half‐fluence PDT is the only viable treatment option for patients with cCSC. Shortage issues with verteporfin should not lead to the employment of ineffective treatment modalities, as they put patients at unnecessary risk of adverse events.
Like
Save
Share